Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vinblastine with or without Bevacizumab in pediatric low grade glioma
2017-001982-26Phase 2Unknown
- Sponsor
- SickKids
- Start
- Sep 2017
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics, Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial in low-grade glioma (LGG) comparing Vinblastine monotherapy with Vinblastine + bevacizumab (2 arms). Primary endpoint: Response rate at 6 months. Status: unknown.
02
Drugs
bevacizumabvinblastine
03
Conditions
low-grade glioma (LGG)
Beyond the preview
Go deeper on 2017-001982-26.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2017-001982-26.